Moreover, approximately 60% of missed-diagnosed LN status using imaging-based methods were correctly predicted to be LN-positive by the detection of the EV-packaged ELNAT1 in bladder cancer, and thus might serve as an alternative for the diagnosis of LN metastasis11. Here, SNHG16 is linked to urinary bladder cancer.